Physicochemical Properties
| Molecular Formula | C14H10IN3OS |
| Molecular Weight | 395.219 |
| Exact Mass | 394.959 |
| Elemental Analysis | C, 42.55; H, 2.55; I, 32.11; N, 10.63; O, 4.05; S, 8.11 |
| CAS # | 478482-75-6 |
| PubChem CID | 6539732 |
| Appearance | White to off-white solid powder |
| LogP | 4.028 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 20 |
| Complexity | 304 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | ZRHRPGSSSVYBRG-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C14H10IN3OS/c15-12-3-1-2-10(8-12)9-20-14-18-17-13(19-14)11-4-6-16-7-5-11/h1-8H,9H2 |
| Chemical Name | Pyridine, 4-[5-[[(3-iodophenyl)methyl]thio]-1,3,4-oxadiazol-2-yl]- |
| Synonyms | Glycogen synthase kinase 3β inhibitor II; GSK-3 inhibitor II; KIN 001-042; KIN-001-042; KIN001-042; KIN001042; KIN 001042; KIN-001042; |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | GSK3β inhibitor II reacts ionic to Lys85, hydrogen bonds to Lys85 and Val135 residues, and correspondingly to Ile62, Phe67, Val70, Ala83, and Leu188 residues [1]. Val135 and GSK3β inhibitor II establish a hydrogen bond[1]. |
| References |
[1]. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation. J Biomol Struct Dyn. 2021 Nov;39(18):7065-7079. |
| Additional Infomation | 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole is an aryl sulfide. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~50 mg/mL (~126.51 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (5.26 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.5302 mL | 12.6512 mL | 25.3024 mL | |
| 5 mM | 0.5060 mL | 2.5302 mL | 5.0605 mL | |
| 10 mM | 0.2530 mL | 1.2651 mL | 2.5302 mL |